Highlights
For the three months ended
- Revenues of
$691.5 million - Book-to-bill ratio of 1.12x, resulting in 1.12x book-to-bill for the trailing 12 months
- GAAP net income of
$0.6 million , or$0.01 per diluted share - Adjusted EBITDA of
$58.0 million - Adjusted net income of
$27.9 million , or$0.28 per diluted share - Cash provided by operations of
$60.8 million and free cash flow of$52.5 million - Raised midpoints of full-year revenue and adjusted EBITDA guidance and narrowed ranges
“Fortrea delivered another quarter of progress on our return-to-growth strategy, reflecting stronger commercial execution, continued operational improvements and financial discipline,” said
Third Quarter 2026 Financial Results
Revenue for the third quarter was
Third quarter GAAP net income was
During the third quarter, the Company performed a detailed review of contracts included in its backlog. As a result, the Company reduced backlog by
Year-to-Date 2026 Financial Results
Year-to-date revenue was
Year-to-date GAAP net loss was
2026 Financial Guidance
The Company updated its full-year 2026 guidance, narrowing the revenue and adjusted EBITDA ranges and raising both midpoints. The Company now expects revenues of
Earnings Call and Replay
Fortrea will host a conference call at
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services, delivered in highly flexible models that include full service, functional service provider and hybrid service structures. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, technology innovation and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn, X and Bluesky.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, the Company’s 2026 financial guidance. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “guidance,” “expect,” “assume,” “anticipate,” “intend,” “plan,” “forecast,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements, including the Company’s 2026 financial guidance, are not guarantees of future performance and are subject to known and unknown risks and uncertainties, many of which are beyond the Company’s control. Actual results may differ materially from the Company’s expectations due to a number of factors, including, but not limited to, the following: the Company’s dependence on third parties generally to provide services critical to its businesses; the Company’s ability to successfully implement the Company’s business strategies and execute the Company’s long-term value creation strategy; risks and expenses associated with the Company’s international operations, tariff policies, trade sanctions and other trade restrictions and currency fluctuations; the anticipated benefits of the Company’s acquisition of the Early Phase Services division of
Note on Non-GAAP Financial Measures
This release includes information based on financial measures that are not recognized under generally accepted accounting principles in
The Company uses non-GAAP measures in its operational and financial decision making and believes that it is useful to exclude certain items in order to focus on what it regards to be a more meaningful indicator of the underlying operating performance of the business. For example, in calculating Adjusted EBITDA, the Company excludes all the amortization of intangible assets associated with acquired customer relationships and backlog, databases, non-compete agreements and trademarks, trade names and other from non-GAAP expense and income measures, as such amounts can be significantly impacted by the timing and size of acquisitions. Although the Company excludes amortization of acquired intangible assets from the Company’s non-GAAP expenses, the Company believes that it is important for investors to understand that revenue generated from such intangibles is included within revenue in determining net income attributable to the Company. Internal management reports feature non-GAAP measures which are also used to prepare strategic plans and annual budgets and review management compensation. The Company also believes that investors may find non-GAAP financial measures useful for the same reasons, although investors are cautioned that non-GAAP financial measures are not a substitute for GAAP disclosures.
The non-GAAP financial measures are not presented in accordance with GAAP. Please refer to the schedules attached to this release for relevant definitions and reconciliations of non-GAAP financial measures contained herein to the most directly comparable GAAP measures. The Company’s full-year 2026 guidance measures (other than revenue) are provided on a non-GAAP basis without a reconciliation to the most directly comparable GAAP measure because the Company is unable to predict with a reasonable degree of certainty certain items contained in the GAAP measures without unreasonable efforts. Such items include, but are not limited to, acquisition-related expenses, restructuring and related expenses, goodwill impairment, stock-based compensation and other items not reflective of the Company's ongoing operations.
Non-GAAP measures are frequently used by securities analysts, investors and other interested parties in their evaluation of companies comparable to the Company, many of which present non-GAAP measures when reporting their results. Non-GAAP measures have limitations as an analytical tool. They are not presentations made in accordance with GAAP, are not measures of financial condition or liquidity and should not be considered as an alternative to profit or loss for the period determined in accordance with GAAP or operating cash flows determined in accordance with GAAP. Non-GAAP measures are not necessarily comparable to similarly titled measures used by other companies. As a result, you should not consider such performance measures in isolation from, or as a substitute analysis for, the Company’s results of operations as determined in accordance with GAAP.
Fortrea Contacts
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in millions, except per share data) (unaudited) | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenues | $ | 691.5 | $ | 701.3 | $ | 2,006.2 | $ | 2,062.9 | |||||||
| Costs and expenses: | |||||||||||||||
| Direct costs, exclusive of depreciation and amortization | 552.0 | 578.6 | 1,603.9 | 1,690.2 | |||||||||||
| Selling, general and administrative expenses, exclusive of depreciation and amortization | 103.8 | 106.8 | 306.4 | 353.4 | |||||||||||
| Depreciation and amortization | 20.0 | 19.6 | 59.4 | 58.7 | |||||||||||
| — | — | — | 797.9 | ||||||||||||
| Restructuring and other charges | 0.7 | 4.9 | 10.1 | 21.7 | |||||||||||
| Total costs and expenses | 676.5 | 709.9 | 1,979.8 | 2,921.9 | |||||||||||
| Operating income (loss) | 15.0 | (8.6 | ) | 26.4 | (859.0 | ) | |||||||||
| Other income (expense): | |||||||||||||||
| Interest expense | (20.2 | ) | (22.6 | ) | (58.6 | ) | (68.2 | ) | |||||||
| Foreign exchange gain (loss) | 1.3 | (2.6 | ) | 14.5 | (28.1 | ) | |||||||||
| Other, net | 0.3 | 5.1 | 0.6 | 7.9 | |||||||||||
| Loss before income taxes | (3.6 | ) | (28.7 | ) | (17.1 | ) | (947.4 | ) | |||||||
| Income tax (benefit) expense | (4.2 | ) | (12.8 | ) | 19.1 | 6.3 | |||||||||
| Net income (loss) | $ | 0.6 | $ | (15.9 | ) | $ | (36.2 | ) | $ | (953.7 | ) | ||||
| Earnings (loss) per common share | |||||||||||||||
| Basic and diluted | $ | 0.01 | $ | (0.17 | ) | $ | (0.38 | ) | $ | (10.53 | ) | ||||
CONDENSED CONSOLIDATED BALANCE SHEETS (dollars and shares in millions) (unaudited) | |||||||
2026 | 2025 | ||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 220.6 | $ | 174.6 | |||
| Accounts receivable and unbilled services, net | 641.1 | 589.7 | |||||
| Prepaid expenses and other | 91.0 | 132.9 | |||||
| Total current assets | 952.7 | 897.2 | |||||
| Property, plant and equipment, net | 158.6 | 149.5 | |||||
| 949.9 | 960.0 | ||||||
| Intangible assets, net | 572.0 | 622.0 | |||||
| Deferred income taxes | 6.2 | 6.2 | |||||
| Other assets, net | 98.8 | 80.8 | |||||
| Total assets | $ | 2,738.2 | $ | 2,715.7 | |||
| LIABILITIES AND EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 53.0 | $ | 29.7 | |||
| Accrued expenses and other current liabilities | 372.1 | 395.8 | |||||
| Unearned revenue | 525.5 | 473.8 | |||||
| Current portion of long-term debt | 23.4 | 4.8 | |||||
| Short-term operating lease liabilities | 9.3 | 9.2 | |||||
| Total current liabilities | 983.3 | 913.3 | |||||
| Long-term debt, less current portion | 1,031.9 | 1,048.0 | |||||
| Operating lease liabilities | 53.8 | 54.0 | |||||
| Deferred income taxes and other tax liabilities | 97.1 | 97.6 | |||||
| Other liabilities | 39.8 | 39.3 | |||||
| Total liabilities | 2,205.9 | 2,152.2 | |||||
| Commitments and contingent liabilities | |||||||
| Equity: | |||||||
| Common stock, 96.5 and 93.1 shares outstanding at | 0.1 | 0.1 | |||||
| Additional paid-in capital | 2,152.6 | 2,116.6 | |||||
| Accumulated deficit | (1,419.4 | ) | (1,383.2 | ) | |||
| Accumulated other comprehensive loss | (201.0 | ) | (170.0 | ) | |||
| Total equity | 532.3 | 563.5 | |||||
| Total liabilities and equity | $ | 2,738.2 | $ | 2,715.7 | |||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in millions) (unaudited) | |||||||
| Nine Months Ended | |||||||
| 2026 | 2025 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net loss | $ | (36.2 | ) | $ | (953.7 | ) | |
| Adjustments to reconcile net loss to net cash provided by (used for) operating activities: | |||||||
| Depreciation and amortization | 59.4 | 58.7 | |||||
| Stock compensation | 36.0 | 59.6 | |||||
| Credit loss expense | 4.0 | 13.5 | |||||
| Operating lease right-of-use asset expense | 6.2 | 8.6 | |||||
| Operating lease right-of-use asset impairment | — | 1.3 | |||||
| — | 797.9 | ||||||
| Deferred income taxes | 1.0 | (24.4 | ) | ||||
| Unrealized foreign exchange movements | (13.2 | ) | 38.8 | ||||
| Other, net | 2.8 | 2.2 | |||||
| Changes in assets and liabilities: | |||||||
| Increase in accounts receivable and unbilled services, net | (55.3 | ) | (10.6 | ) | |||
| Decrease in prepaid expenses and other | 20.3 | 43.8 | |||||
| Increase (decrease) in accounts payable | 23.7 | (89.7 | ) | ||||
| Increase in unearned revenue | 51.0 | 54.6 | |||||
| Decrease in accrued expenses and other | (27.0 | ) | (16.2 | ) | |||
| Net cash provided by (used for) operating activities | 72.7 | (15.6 | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Capital expenditures | (25.3 | ) | (17.7 | ) | |||
| Proceeds from sale of business, net | — | 39.6 | |||||
| Proceeds from sale of assets | 2.0 | — | |||||
| Net cash (used for) provided by investing activities | (23.3 | ) | 21.9 | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Proceeds from revolving credit facilities | — | 453.9 | |||||
| Payments on revolving credit facilities | — | (453.9 | ) | ||||
| Debt issuance costs | — | (0.6 | ) | ||||
| Net cash used for financing activities | — | (0.6 | ) | ||||
| Effect of exchange rate changes on cash and cash equivalents | (3.4 | ) | 7.1 | ||||
| Net change in cash and cash equivalents | 46.0 | 12.8 | |||||
| Cash and cash equivalents at beginning of period | 174.6 | 118.5 | |||||
| Cash and cash equivalents at end of period | $ | 220.6 | $ | 131.3 | |||
| RECONCILIATION OF NON-GAAP MEASURES NET INCOME TO ADJUSTED EBITDA RECONCILIATION (in millions) (unaudited) | |||||||||||||||||||
| Trailing Twelve Months Ended | Three Months Ended | Nine Months Ended | |||||||||||||||||
2026 | 2026 | 2025 | 2026 | 2025 | |||||||||||||||
| Adjusted EBITDA: | |||||||||||||||||||
| Net income (loss) | $ | (68.7 | ) | $ | 0.6 | $ | (15.9 | ) | $ | (36.2 | ) | $ | (953.7 | ) | |||||
| Income tax expense (benefit) | 16.0 | (4.2 | ) | (12.8 | ) | 19.1 | 6.3 | ||||||||||||
| Interest expense | 81.8 | 20.2 | 22.6 | 58.6 | 68.2 | ||||||||||||||
| Foreign exchange (gain) loss | (15.7 | ) | (1.3 | ) | 2.6 | (14.5 | ) | 28.1 | |||||||||||
| Depreciation and amortization (a) | 78.7 | 20.0 | 19.6 | 59.4 | 58.7 | ||||||||||||||
| — | — | — | — | 797.9 | |||||||||||||||
| Restructuring and other charges (b) | 38.0 | 1.4 | 6.3 | 12.7 | 23.8 | ||||||||||||||
| Stock based compensation | 50.8 | 12.0 | 22.3 | 36.0 | 59.6 | ||||||||||||||
| Acquisition and disposition-related costs (c) | 3.9 | 2.8 | 2.3 | 2.8 | 8.9 | ||||||||||||||
| One-time spin-related costs (d) | 2.3 | — | 3.0 | 1.0 | 23.4 | ||||||||||||||
| CEO transition related costs | — | — | 0.3 | — | 5.1 | ||||||||||||||
| Receivables securitization yield expense | 17.3 | 4.2 | 4.5 | 13.0 | 13.4 | ||||||||||||||
| Cloud computing arrangements (e) | 4.6 | 1.2 | 0.9 | 3.6 | 2.1 | ||||||||||||||
| Other (f) | 8.7 | 1.1 | (5.0 | ) | 8.2 | (5.9 | ) | ||||||||||||
| Adjusted EBITDA | $ | 217.7 | $ | 58.0 | $ | 50.7 | $ | 163.7 | $ | 135.9 | |||||||||
(a) Includes amortization of intangible assets acquired as part of business acquisitions.
(b) Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions, organizational realignment initiatives, and other actions taken to reduce overcapacity, align resources and facilities, and restructure certain operations.
(c) Acquisition-related costs include transaction, integration, and other direct and incremental costs incurred in connection with acquisitions. Disposition-related costs are short-term incremental costs to support the transition services agreement associated with the sale of the Enabling Services Segment.
(d) Represents one-time or incremental costs required to implement capabilities to exit the transition services agreement with the Company’s former parent.
(e) Represents amortization of implementation costs deferred in connection with cloud computing arrangements.
(f) Includes adjustments to estimated contingent consideration on a sale of a facility, income related to services provided under transition services agreements, certain legal expenses related to specifically identified litigation matters, including the shareholder litigation and the CFO transition-related litigation, settlements related to litigation initiated prior to the spinoff of the Company as a standalone company, and non-recurring business advisory consulting services.
NET INCOME TO ADJUSTED NET INCOME RECONCILIATION (in millions, except per share data) (unaudited) | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Adjusted net income: | |||||||||||||||
| Net income (loss) | $ | 0.6 | $ | (15.9 | ) | $ | (36.2 | ) | $ | (953.7 | ) | ||||
| Foreign exchange (gain) loss | (1.3 | ) | 2.6 | (14.5 | ) | 28.1 | |||||||||
| Amortization (a) | 14.5 | 14.8 | 43.7 | 43.9 | |||||||||||
| — | — | — | 797.9 | ||||||||||||
| Restructuring and other charges (b) | 1.4 | 6.3 | 12.7 | 23.8 | |||||||||||
| Stock based compensation | 12.0 | 22.3 | 36.0 | 59.6 | |||||||||||
| Acquisition and disposition-related costs (c) | 2.8 | 2.3 | 2.8 | 8.9 | |||||||||||
| One-time spin-related costs (d) | — | 3.0 | 1.0 | 23.4 | |||||||||||
| CEO transition related costs | — | 0.3 | — | 5.1 | |||||||||||
| Receivables securitization yield expense | 4.2 | 4.5 | 13.0 | 13.4 | |||||||||||
| Cloud computing arrangements (e) | 1.2 | 0.9 | 3.6 | 2.1 | |||||||||||
| Other (f) | 1.1 | (5.0 | ) | 8.2 | (5.9 | ) | |||||||||
| Income tax impact of adjustments (g) | (8.6 | ) | (24.4 | ) | (4.5 | ) | (15.4 | ) | |||||||
| Adjusted net income | $ | 27.9 | $ | 11.7 | $ | 65.8 | $ | 31.2 | |||||||
| Basic shares | 95.6 | 91.2 | 94.6 | 90.6 | |||||||||||
| Diluted shares | 101.2 | 93.8 | 99.6 | 92.0 | |||||||||||
| Adjusted basic EPS | $ | 0.29 | $ | 0.13 | $ | 0.70 | $ | 0.34 | |||||||
| Adjusted diluted EPS | $ | 0.28 | $ | 0.12 | $ | 0.66 | $ | 0.34 | |||||||
(a) Includes amortization of intangible assets acquired as part of business acquisitions.
(b) Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions, organizational realignment initiatives, and other actions taken to reduce overcapacity, align resources and facilities, and restructure certain operations.
(c) Acquisition-related costs include transaction, integration, and other direct and incremental costs incurred in connection with acquisitions. Disposition-related costs are short-term incremental costs to support the transition services agreement associated with the sale of the Enabling Services Segment.
(d) Represents one-time or incremental costs required to implement capabilities to exit the transition services agreement with the Company’s former parent.
(e) Represents amortization of implementation costs deferred in connection with cloud computing arrangements.
(f) Includes adjustments to estimated contingent consideration on a sale of a facility, income related to services provided under transition services agreements, certain legal expenses related to specifically identified litigation matters, including the shareholder litigation and the CFO transition-related litigation, settlements related to litigation initiated prior to the spinoff of the Company as a standalone company, and non-recurring business advisory consulting services.
(g) Income tax impact of adjustments represents the amount of additional tax expense that the Company estimates it would record if it used Non-GAAP results instead of GAAP results in the calculation of its provision.
NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW RECONCILIATION (in millions) (unaudited) | |||||||
| Three Months Ended | Nine Months Ended | ||||||
| Net cash provided by operating activities | $ | 60.8 | $ | 72.7 | |||
| Capital expenditures | (8.3 | ) | (25.3 | ) | |||
| Free cash flow | $ | 52.5 | $ | 47.4 | |||
Source: